Innovating on the Shoulders of Giants
In this Interview
Dr. Johnson is an internationally-respected developer and evaluator of clinical information technology. His research interests have been related to developing and encouraging the adoption of clinical information systems to improve patient safety and compliance with practice guidelines; the uses of advanced computer technologies, including the Worldwide Web, personal digital assistants, and pen-based computers in medicine; and the development of computer-based documentation systems for the point of care. In the early phases of his career, he directed the development and evaluation of evidence-based pediatric care guidelines for The Johns Hopkins Hospital. He has been principal investigator on numerous grants, and has been an invited speaker at most major medical informatics and pediatrics conferences. He is the author of over 100 publications and books or book chapters. He is a former recipient of the Robert Wood Johnson Foundation’s Harold Amos Medical Faculty Development Award and is also a recipient of the American Academy of Pediatrics Byron B. Oberst Award in recognition of his informatics education efforts. At Vanderbilt, he has been a member of the Academy for Excellence in Education since 2008. He was elected into the American College of Medical Informatics in 2004, The Academic Pediatric Society in 2010, and the National Academy of Medicine (Institute of Medicine) in 2010. Dr. Johnson leads the American Board of Pediatrics Informatics Task Force, and has been appointed to ONC's Health IT Standards Committee, as well as the NLM's Board of Scientific Counselors. He has held numerous leadership positions within the American Medical Informatics Association and the American Academy of Pediatrics.
Blake Marggraff co-founded Epharmix, the leader in evidence-based remote patient monitoring. Epharmix helps risk-bearing healthcare organizations succeed in value-based care by enabling care managers to communicate with their high and rising-risk patients more efficiently. Epharmix sends automated, proactive SMS texts and calls with disease-specific messages to the patient's own phone to gather key patient biometrics and self-reported symptoms. This information is run through Epharmix algorithms providing relevant actionable alerts and trending so that clinical teams deliver timely outreach and prevent an unnecessary ED visit or exacerbation. In addition to his passion for transforming healthcare through Epharmix, Blake is a Board Member of the Institute for Family Medicine.